| Over the past | Total investment | Would've become | Historic returns | Returns |
|---|---|---|---|---|
| 6 months | ₹30,000 | ₹32,236 | +7.45% | |
| 1 year | ₹60,000 | ₹64,378 | +7.30% | |
| 3 years | ₹1,80,000 | ₹2,26,135 | +25.63% | |
| 5 years | ₹3,00,000 | ₹4,46,053 | +48.68% |
| Name | Sector | Instruments | Assets |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 11.22% |
| Apollo Hospitals Enterprise Ltd | Healthcare | Equity | 6.52% |
| Torrent Pharmaceuticals Ltd | Healthcare | Equity | 6.50% |
| Aurobindo Pharma Ltd | Healthcare | Equity | 5.15% |
| Divi's Laboratories Ltd | Healthcare | Equity | 4.74% |
| Fortis Healthcare Ltd | Healthcare | Equity | 4.70% |
| Neuland Laboratories Ltd | Healthcare | Equity | 4.59% |
| Onesource Specialty Pharma Ltd | Healthcare | Equity | 4.56% |
| Piramal Pharma Ltd | Healthcare | Equity | 4.33% |
| Repo | Unspecified | Repo | 4.17% |
| Glenmark Pharmaceuticals Ltd | Healthcare | Equity | 3.41% |
| Navin Fluorine International Ltd | Materials | Equity | 3.32% |
| Alkem Laboratories Ltd | Healthcare | Equity | 3.20% |
| Cipla Ltd | Healthcare | Equity | 3.03% |
| Ipca Laboratories Ltd | Healthcare | Equity | 3.01% |
| Abbott India Ltd | Healthcare | Equity | 2.91% |
| Gland Pharma Ltd | Healthcare | Equity | 2.91% |
| Concord Biotech Ltd. | Healthcare | Equity | 2.77% |
| Artemis Medicare Services Ltd | Healthcare | Equity | 2.70% |
| Metropolis Healthcare Ltd | Healthcare | Equity | 2.67% |
| Mankind Pharma Ltd. | Healthcare | Equity | 2.28% |
| Anthem Biosciences Ltd. | Healthcare | Equity | 2.28% |
| Dr. Agarwal’S Health Care Ltd. | Healthcare | Equity | 2.08% |
| Global Health Ltd | Healthcare | Equity | 1.98% |
| Max Healthcare Institute Ltd | Healthcare | Equity | 1.97% |
| Ami Organics Ltd | Healthcare | Equity | 1.93% |
| Vinati Organics Ltd | Materials | Equity | 1.37% |
| Net Payables | Unspecified | Net Payables | -0.29% |
| Name | 1Y | 3Y | 5Y | All |
|---|---|---|---|---|
| Fund returns | +8.2% | +23.6% | +11.6% | +18.3% |
| Category average (Equity Sectoral) | -2.1% | +22.1% | +14.6% | -- |
| Rank (Equity Sectoral) | 12 | 6 | 7 | -- |